
Global Mycobacterium Tuberculosis Testing Market Growth (Status and Outlook) 2025-2031
Description
According to this study, the global Mycobacterium Tuberculosis Testing market size will reach US$ million by 2031.
Tuberculosis is an infectious disease caused by mycobacterium tuberculosis and mainly affects the lungs.
United States market for Mycobacterium Tuberculosis Testing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Mycobacterium Tuberculosis Testing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Mycobacterium Tuberculosis Testing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Mycobacterium Tuberculosis Testing players cover Thermo Fisher Scientific, Danaher, Mediven, Osang Healthcare, Hologic, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “Mycobacterium Tuberculosis Testing Industry Forecast” looks at past sales and reviews total world Mycobacterium Tuberculosis Testing sales in 2024, providing a comprehensive analysis by region and market sector of projected Mycobacterium Tuberculosis Testing sales for 2025 through 2031. With Mycobacterium Tuberculosis Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Mycobacterium Tuberculosis Testing industry.
This Insight Report provides a comprehensive analysis of the global Mycobacterium Tuberculosis Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Mycobacterium Tuberculosis Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Mycobacterium Tuberculosis Testing market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Mycobacterium Tuberculosis Testing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Mycobacterium Tuberculosis Testing.
This report presents a comprehensive overview, market shares, and growth opportunities of Mycobacterium Tuberculosis Testing market by product type, application, key players and key regions and countries.
Segmentation by Type:
Point of Care Test
Nuclear Acid Amplification Tests
Tuberculosis Skin Test
Others
Segmentation by Application:
Hospitals
Specialty Clinics
Diagnostic Laboratories
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Thermo Fisher Scientific
Danaher
Mediven
Osang Healthcare
Hologic
Roche
Abbott
Novacyt
DAAN Gene
Please note: The report will take approximately 2 business days to prepare and deliver.
Tuberculosis is an infectious disease caused by mycobacterium tuberculosis and mainly affects the lungs.
United States market for Mycobacterium Tuberculosis Testing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Mycobacterium Tuberculosis Testing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Mycobacterium Tuberculosis Testing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Mycobacterium Tuberculosis Testing players cover Thermo Fisher Scientific, Danaher, Mediven, Osang Healthcare, Hologic, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “Mycobacterium Tuberculosis Testing Industry Forecast” looks at past sales and reviews total world Mycobacterium Tuberculosis Testing sales in 2024, providing a comprehensive analysis by region and market sector of projected Mycobacterium Tuberculosis Testing sales for 2025 through 2031. With Mycobacterium Tuberculosis Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Mycobacterium Tuberculosis Testing industry.
This Insight Report provides a comprehensive analysis of the global Mycobacterium Tuberculosis Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Mycobacterium Tuberculosis Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Mycobacterium Tuberculosis Testing market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Mycobacterium Tuberculosis Testing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Mycobacterium Tuberculosis Testing.
This report presents a comprehensive overview, market shares, and growth opportunities of Mycobacterium Tuberculosis Testing market by product type, application, key players and key regions and countries.
Segmentation by Type:
Point of Care Test
Nuclear Acid Amplification Tests
Tuberculosis Skin Test
Others
Segmentation by Application:
Hospitals
Specialty Clinics
Diagnostic Laboratories
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Thermo Fisher Scientific
Danaher
Mediven
Osang Healthcare
Hologic
Roche
Abbott
Novacyt
DAAN Gene
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
84 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Mycobacterium Tuberculosis Testing Market Size by Player
- 4 Mycobacterium Tuberculosis Testing by Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Global Mycobacterium Tuberculosis Testing Market Forecast
- 11 Key Players Analysis
- 12 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.